Mon, Jun 24 - Tue, Jun 25 2019


Singapore, Singapore Singapore, Singapore

  • About the event

    Masaki Iino MD, PhD
    University of Yamanashi, Japan


    Silvia Brandalise
    Centro Infantil Boldrini, Brazil

    Balkiss Bouhaouala
    Medicine of Tunis, Biochemistry, Tunisia

    Prof.Eva Rahman Kabir, PhD
    BRAC University, Bangladesh

    Why should you sponsor?

    • An opportunity to promote your organisation and raise your profile within the wider community;
    • Promote your company name to national and international participants prior to, during and after the Conference, these include decision makers, scientists, students and community members;
    • Your representative can mix informally with professionals from industry and academia from all around the world;
    • Your company support of the Conference will be acknowledged widely through web-based and printed material;

    Program Manager

    Key Discussions on Biosimilars 2019

    • Current regulatory status of biosimilar medicines in the EU
    • Market access and regulatory developments
    • Sustainability of the biosimilar medicines sector
    • Advances and convergence of regulatory science
    • Regulatory requirements, scientific and operational challenges
    • Biosimilar Development and Manufacturing
    • Pharmacovigilance
    • Clinical Trials
    • Legal Considerations on Biosimilars
    • FDA-Approved biosimilar products
    • Prescribing biosimilar and generics drugs

    Contact the Organizer Contact the Organizer

  • 101-250 attendees expected

    50% Male Attendees

    50% Female Attendees

Contact the Organizer

✓ Valid Invalid email
✓ Valid Invalid number
This event contains prohibited content? Report it here.

Receive similar events to your mailbox?

Yes I want!

Contact the Organizer

✓ Valid Invalid number